Skandinaviska Enskilda Banken (SEB)’s Verona Pharma VRNA Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-36,600	Closed	-$3.9M	–	834
2025 Q3	$3.9M	Buy	+36,600	New	+$3.82M	0.02%	457

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s VRNA Position: Q4 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 36,600 shares — an estimated $3.9M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $3.9M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Skandinaviska Enskilda Banken (SEB) reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 36,600 Verona Pharma shares in Q4 2025, an estimated $3.9M.
Skandinaviska Enskilda Banken (SEB) first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Skandinaviska Enskilda Banken (SEB)'s Verona Pharma position peaked at $3.9M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2025, filed 12 Feb 2026.